You are here:
Home
NICE Guidance
Conditions and diseases
Blood and immune system conditions
Blood and bone marrow cancers
Isatuximab in combination as induction therapy for untreated multiple myeloma when an autologous stem cell transplant is suitable [TSID11949]
Awaiting development
Reference number:
GID-TA11465
Expected publication date: TBC
Project information
Project documents
Documents
Documents created during the development process.
Topic selection
Topic selection
Back to top